Variant report

Variant	nsv1057226
Chromosome Location	chr17:18283687-18510146
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:1466)
CpG islands
(count:2198)
Chromatin interactive
region (count:5)
LncRNA
region (count:91)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:1466 , 50 per page) page: 1 2 3 4 5 6 7 ... 30

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ARID3A	chr17:18467518-18467720	HepG2	liver:	n/a	n/a
2	ATF2	chr17:18314118-18314356	H1-hESC	embryonic stem cell:	n/a	n/a
3	BACH1	chr17:18355389-18355575	H1-hESC	embryonic stem cell:	n/a	n/a
4	BACH1	chr17:18362390-18362672	H1-hESC	embryonic stem cell:	n/a	n/a
5	BACH1	chr17:18472043-18472169	H1-hESC	embryonic stem cell:	n/a	n/a
6	BATF	chr17:18396335-18396562	GM12878	blood:	n/a	chr17:18396479-18396490
7	BATF	chr17:18379787-18380078	GM12878	blood:	n/a	n/a
8	BATF	chr17:18503769-18504272	GM12878	blood:	n/a	n/a
9	BATF	chr17:18509282-18509509	GM12878	blood:	n/a	n/a
10	BATF	chr17:18483425-18483804	GM12878	blood:	n/a	n/a
11	BATF	chr17:18410950-18411370	GM12878	blood:	n/a	chr17:18411156-18411166 chr17:18411155-18411166
12	BATF	chr17:18306836-18307314	GM12878	blood:	n/a	n/a
13	BATF	chr17:18496542-18496830	GM12878	blood:	n/a	n/a
14	BATF	chr17:18306799-18307466	GM12878	blood:	n/a	n/a
15	BATF	chr17:18396259-18396664	GM12878	blood:	n/a	chr17:18396479-18396490
16	BATF	chr17:18411051-18411300	GM12878	blood:	n/a	chr17:18411156-18411166 chr17:18411155-18411166
17	BATF	chr17:18483436-18483734	GM12878	blood:	n/a	n/a
18	BATF	chr17:18379801-18380128	GM12878	blood:	n/a	n/a
19	BATF	chr17:18509195-18509490	GM12878	blood:	n/a	n/a
20	BATF	chr17:18467472-18467685	GM12878	blood:	n/a	n/a
21	BATF	chr17:18301531-18301764	GM12878	blood:	n/a	n/a
22	BCL11A	chr17:18472933-18473174	H1-hESC	embryonic stem cell:	n/a	n/a
23	BCL11A	chr17:18483453-18483768	GM12878	blood:	n/a	n/a
24	BCL11A	chr17:18306873-18307246	GM12878	blood:	n/a	n/a
25	BCL11A	chr17:18424410-18424651	GM12878	blood:	n/a	n/a
26	BCL11A	chr17:18379766-18380162	GM12878	blood:	n/a	n/a
27	BCL11A	chr17:18472981-18473247	H1-hESC	embryonic stem cell:	n/a	n/a
28	BCL11A	chr17:18306911-18307191	GM12878	blood:	n/a	n/a
29	BCL11A	chr17:18509267-18509452	GM12878	blood:	n/a	n/a
30	BCL11A	chr17:18503757-18504030	GM12878	blood:	n/a	n/a
31	BCL11A	chr17:18378052-18378384	GM12878	blood:	n/a	n/a
32	BCL11A	chr17:18379825-18380074	GM12878	blood:	n/a	n/a
33	BCL11A	chr17:18509177-18509596	GM12878	blood:	n/a	n/a
34	BCL3	chr17:18314773-18315245	A549	lung:	n/a	n/a
35	BHLHE40	chr17:18284936-18285074	K562	blood:	n/a	n/a
36	BHLHE40	chr17:18466647-18467016	K562	blood:	n/a	n/a
37	BHLHE40	chr17:18396537-18396565	K562	blood:	n/a	n/a
38	BHLHE40	chr17:18424672-18424862	GM12878	blood:	n/a	n/a
39	CEBPB	chr17:18362210-18362602	Hela-S3	cervix:	n/a	chr17:18362363-18362376
40	CEBPB	chr17:18467442-18467753	Hela-S3	cervix:	n/a	n/a
41	CEBPB	chr17:18508639-18509020	K562	blood:	n/a	n/a
42	CEBPB	chr17:18318052-18318134	A549	lung:	n/a	chr17:18318100-18318113 chr17:18318102-18318113 chr17:18318102-18318111
43	CEBPB	chr17:18362356-18362662	IMR90	lung:	n/a	chr17:18362363-18362376
44	CEBPB	chr17:18317946-18318165	IMR90	lung:	n/a	chr17:18318100-18318113 chr17:18318102-18318113 chr17:18318102-18318111
45	CEBPB	chr17:18509221-18509565	K562	blood:	n/a	n/a
46	CEBPB	chr17:18467515-18467676	HepG2	liver:	n/a	n/a
47	CEBPB	chr17:18484451-18484641	A549	lung:	n/a	n/a
48	CEBPB	chr17:18484454-18484578	H1-hESC	embryonic stem cell:	n/a	n/a
49	CEBPB	chr17:18509247-18509490	K562	blood:	n/a	n/a
50	CEBPB	chr17:18322055-18322251	K562	blood:	n/a	n/a

(count:2198 , 50 per page) page: 1 2 3 4 5 6 7 ... 44

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr17:18431043-18431093	HEK293	kidney:	embryo
2	chr17:18285810-18285860	GM12891	blood:	n/a
3	chr17:18431043-18431093	HEK293	kidney:	embryo
4	chr17:18285810-18285860	GM12891	blood:	n/a
5	chr17:18397849-18397899	T-47D	breast:	n/a
6	chr17:18380159-18380209	T-47D	breast:	n/a
7	chr17:18432149-18432199	PFSK-1	brain:	n/a
8	chr17:18305305-18305355	SAEC	small airway:	n/a
9	chr17:18324895-18324945	K562	blood:	n/a
10	chr17:18378879-18378929	HAEpiC	amniotic membrane:	n/a
11	chr17:18291699-18291749	AoSMC	blood vessel:	n/a
12	chr17:18285838-18285888	GM12878	blood:	n/a
13	chr17:18378879-18378929	GM12891	blood:	n/a
14	chr17:18379129-18379179	ECC-1	luminal epithelium:	n/a
15	chr17:18378879-18378929	HCT-116	colon:	n/a
16	chr17:18378879-18378929	NHDF-neo	bronchial:	n/a
17	chr17:18286644-18286694	NT2-D1	testis:	n/a
18	chr17:18430908-18430958	MCF-7	breast:	n/a
19	chr17:18431043-18431093	HMEC	breast:	n/a
20	chr17:18475978-18476028	GM12891	blood:	n/a
21	chr17:18421335-18421385	AG04450	lung:	fetal
22	chr17:18476310-18476360	MCF-7	breast:	n/a
23	chr17:18476310-18476360	AG04450	lung:	fetal
24	chr17:18291699-18291749	T-47D	breast:	n/a
25	chr17:18421335-18421385	HRPEpiC	eye:	n/a
26	chr17:18475978-18476028	AG10803	skin:	n/a
27	chr17:18428092-18428142	ovcar-3	ovarian:	n/a
28	chr17:18290668-18290718	HL-60	blood:	n/a
29	chr17:18431043-18431093	GM19239	blood:	n/a
30	chr17:18305305-18305355	HRE	kidney:	n/a
31	chr17:18475978-18476028	SK-N-SH	brain:	n/a
32	chr17:18286644-18286694	IMR90	lung:	fetal
33	chr17:18475978-18476028	NH-A	brain:	n/a
34	chr17:18419896-18419946	GM12878	blood:	n/a
35	chr17:18476059-18476109	GM12891	blood:	n/a
36	chr17:18317909-18317959	AG10803	skin:	n/a
37	chr17:18419896-18419946	ECC-1	luminal epithelium:	n/a
38	chr17:18324895-18324945	HCPEpiC	choroid plexus:	n/a
39	chr17:18283678-18283728	CMK	blood:	n/a
40	chr17:18380159-18380209	AG09319	gingival:	n/a
41	chr17:18285838-18285888	HRPEpiC	eye:	n/a
42	chr17:18287814-18287864	Caco-2	colon:	n/a
43	chr17:18380159-18380209	HRE	kidney:	n/a
44	chr17:18313048-18313098	HCF	heart:	n/a
45	chr17:18430908-18430958	HCM	heart:	n/a
46	chr17:18432149-18432199	NHDF-neo	bronchial:	n/a
47	chr17:18429951-18430001	ovcar-3	ovarian:	n/a
48	chr17:18313048-18313098	BJ	skin:	n/a
49	chr17:18476059-18476109	MCF10A-Er-Src	breast:	n/a
50	chr17:18380354-18380404	NT2-D1	testis:	n/a

(count:5 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr17:18278481..18280376-chr17:18284493..18286607,2	K562	blood:
2	chr17:18222850..18223360-chr17:18466465..18467335,2	MCF-7	breast:
3	chr17:18289123..18291183-chr17:20462480..20465308,2	MCF-7	breast:
4	chr17:18273227..18274953-chr17:18289917..18291736,2	K562	blood:
5	chr17:18271062..18274039-chr17:18283398..18285584,2	MCF-7	breast:

(count:91 , 50 per page) page: 1 2

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-FAM106A-2	chr17:18436395-18436705	NONHSAT146384
2	lnc-FAM106A-2	chr17:18444241-18444550	ENSG00000273018.1
3	lnc-FAM106A-2	chr17:18420604-18420787	NONHSAT146381
4	lnc-FAM106A-2	chr17:18422796-18422988	NONHSAT146381
5	lnc-AL353997.5.1-4	chr17:18344268-18344334	NONHSAT146373
6	lnc-FAM106A-2	chr17:18431887-18432126	NONHSAT146381
7	lnc-FAM106A-2	chr17:18431887-18432061	ENSG00000273018.1
8	lnc-FAM106A-2	chr17:18422796-18422988	NONHSAT146382
9	lnc-FAM106A-2	chr17:18435820-18435911	ENSG00000273018.1
10	lnc-AL353997.5.1-6	chr17:18395939-18396053	NONHSAT146378
11	lnc-FAM106A-2	chr17:18422796-18422988	ENSG00000273018.1
12	lnc-AL353997.1-1	chr17:18289718-18289778	NONHSAT146194
13	lnc-FAM106A-2	chr17:18420696-18420787	ENSG00000273018.1
14	lnc-FAM106A-2	chr17:18427091-18427191	ENSG00000273018.1
15	lnc-FAM106A-2	chr17:18422796-18422988	ENSG00000273018.1
16	lnc-FAM106A-2	chr17:18420725-18420787	ENSG00000273018.1
17	lnc-FAM106A-2	chr17:18445402-18445501	ENSG00000273018.1
18	lnc-FAM106A-2	chr17:18431900-18432061	ENSG00000273018.1
19	lnc-FAM106A-2	chr17:18436661-18436852	ENSG00000273018.1
20	lnc-FAM106A-2	chr17:18445402-18445501	ENSG00000273018.1
21	lnc-AL353997.5.1-1	chr17:18327635-18327951	ENSG00000205266.5
22	lnc-TBC1D28-3	chr17:18508369-18508669	NONHSAT146389
23	lnc-FAM106A-2	chr17:18454820-18455019	ENSG00000273018.1
24	lnc-FAM106A-2	chr17:18427091-18427191	ENSG00000273018.1
25	lnc-FAM106A-2	chr17:18435820-18435911	ENSG00000273018.1
26	lnc-AL353997.5.1-2	chr17:18315660-18315807	XLOC_012131
27	lnc-AL353997.5.1-2	chr17:18317464-18317623	XLOC_012131
28	lnc-FAM106A-2	chr17:18430884-18431074	ENSG00000273018.1
29	lnc-FAM106A-2	chr17:18444241-18444277	NONHSAT146384
30	lnc-FAM106A-1	chr17:18427880-18430160	NR_026809
31	lnc-FAM106A-2	chr17:18426379-18426609	NONHSAT146382
32	lnc-FAM106A-2	chr17:18422796-18422988	ENSG00000273018.1
33	lnc-FAM106A-2	chr17:18435820-18435911	ENSG00000273018.1
34	lnc-AL353997.5.1-2	chr17:18317464-18317702	XLOC_012131
35	lnc-FAM106A-2	chr17:18454820-18455008	ENSG00000273018.1
36	lnc-FAM106A-2	chr17:18446987-18447029	ENSG00000273018.1
37	lnc-FAM106A-2	chr17:18427457-18427714	ENSG00000273018.1
38	lnc-FAM106A-2	chr17:18422796-18422988	ENSG00000273018.1
39	lnc-FAM106A-2	chr17:18445402-18445501	ENSG00000273018.1
40	lnc-AL353997.5.1-4	chr17:18343220-18343625	NONHSAT146373
41	lnc-FAM106A-2	chr17:18436661-18436705	ENSG00000273018.1
42	lnc-FAM106A-2	chr17:18446987-18447029	ENSG00000273018.1
43	lnc-FAM106A-2	chr17:18431887-18431914	ENSG00000273018.1
44	lnc-AL353997.5.1-2	chr17:18315789-18316112	XLOC_012131
45	lnc-FAM106A-2	chr17:18430884-18431074	ENSG00000273018.1
46	lnc-FAM106A-2	chr17:18422796-18422988	ENSG00000273018.1
47	lnc-FAM106A-2	chr17:18446987-18447029	ENSG00000273018.1
48	lnc-FAM106A-2	chr17:18436661-18437376	ENSG00000273018.1
49	lnc-FAM106A-2	chr17:18426965-18427191	ENSG00000273018.1
50	lnc-FAM106A-2	chr17:18420696-18420787	ENSG00000273018.1

No data

Variant related genes	Relation type
ENSG00000205266	TF binding region
USP32P2	TF binding region
ENSG00000267492	TF binding region
KRT16P1	TF binding region
ENSG00000267441	TF binding region
YWHAEP2	TF binding region
EVPLL	TF binding region
KRT17P2	TF binding region
SRP68P2	TF binding region
NOS2P2	TF binding region
TBC1D3P4	TF binding region
ENSG00000264177	TF binding region
KRT16P4	TF binding region
LGALS9C	TF binding region
ENSG00000227919	TF binding region
RN7SL639P	TF binding region
TNPO1P2	TF binding region
ENSG00000240279	TF binding region
ENSG00000227077	TF binding region
FAM106A	TF binding region
ENSG00000220161	TF binding region
CCDC144B	TF binding region
ENSG00000273018	TF binding region
ENSG00000205266	CpG island
USP32P2	CpG island
ENSG00000267492	CpG island
KRT16P1	CpG island
ENSG00000267441	CpG island
YWHAEP2	CpG island
EVPLL	CpG island
KRT17P2	CpG island
SRP68P2	CpG island
NOS2P2	CpG island
TBC1D3P4	CpG island
ENSG00000264177	CpG island
KRT16P4	CpG island
LGALS9C	CpG island
ENSG00000227919	CpG island
RN7SL639P	CpG island
TNPO1P2	CpG island
ENSG00000240279	CpG island
ENSG00000227077	CpG island
FAM106A	CpG island
ENSG00000220161	CpG island
CCDC144B	CpG island
ENSG00000273018	CpG island
ENSG00000263946	chromatin interactions
KIAA0664	miRNA target sites
KIAA0528	miRNA target sites

Extended variants
information (count: 4994 )
Associated
traits (count: 169 )

Variant overlapped rSNPs/rCNVs (count:4994 , 50 per page) page: 1 2 3 4 5 6 7 ... 100

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs61091801	chr17:18283739-18283740	Enhancers Bivalent Enhancer Weak transcription	n/a	n/a	Overlapped CNVs	n/a
2	rs150199232	chr17:18283745-18283746	Enhancers Bivalent Enhancer Weak transcription	n/a	n/a	Overlapped CNVs	n/a
3	rs200462868	chr17:18283746-18283747	Enhancers Bivalent Enhancer Weak transcription	n/a	n/a	Overlapped CNVs	n/a
4	rs386795969	chr17:18283748-18283749	Enhancers Bivalent Enhancer Weak transcription	n/a	n/a	Overlapped CNVs	n/a
5	rs56735648	chr17:18283749-18283750	Enhancers Bivalent Enhancer Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
6	rs376987033	chr17:18283755-18283756	Enhancers Bivalent Enhancer Weak transcription	n/a	n/a	Overlapped CNVs	n/a
7	rs546836714	chr17:18283760-18283761	Enhancers Bivalent Enhancer Weak transcription	n/a	n/a	Overlapped CNVs	n/a
8	rs567056148	chr17:18283804-18283805	Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
9	rs535717971	chr17:18283810-18283811	Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
10	rs555653746	chr17:18283811-18283812	Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
11	rs575564128	chr17:18283835-18283836	Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
12	rs537848590	chr17:18283892-18283893	Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
13	rs139071669	chr17:18283900-18283901	Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
14	rs578005370	chr17:18283906-18283907	Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
15	rs540724833	chr17:18283914-18283915	Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
16	rs143097872	chr17:18283989-18283990	Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
17	rs573794906	chr17:18283990-18283991	Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
18	rs571232184	chr17:18284027-18284028	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
19	rs562749087	chr17:18284053-18284054	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
20	rs138775560	chr17:18284121-18284122	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
21	rs551385806	chr17:18284149-18284150	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
22	rs149300087	chr17:18284157-18284158	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
23	rs527347766	chr17:18284178-18284179	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
24	rs116637662	chr17:18284184-18284185	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
25	rs370013393	chr17:18284185-18284186	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
26	rs535634483	chr17:18284196-18284197	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
27	rs567724594	chr17:18284208-18284209	Weak transcription Enhancers Bivalent Enhancer Strong transcription	n/a	n/a	Overlapped CNVs	n/a
28	rs370420011	chr17:18284234-18284235	Weak transcription Enhancers Bivalent Enhancer Strong transcription	n/a	n/a	Overlapped CNVs	n/a
29	rs386795970	chr17:18284262-18284263	Weak transcription Enhancers Bivalent Enhancer Strong transcription	n/a	n/a	Overlapped CNVs	n/a
30	rs116412205	chr17:18284263-18284264	Weak transcription Enhancers Bivalent Enhancer Strong transcription	n/a	n/a	Overlapped CNVs	n/a
31	rs538160538	chr17:18284266-18284267	Weak transcription Enhancers Bivalent Enhancer Strong transcription	n/a	n/a	Overlapped CNVs	n/a
32	rs557821753	chr17:18284272-18284273	Weak transcription Enhancers Bivalent Enhancer Strong transcription	n/a	n/a	Overlapped CNVs	n/a
33	rs199807942	chr17:18284280-18284281	Weak transcription Enhancers Bivalent Enhancer Strong transcription	n/a	n/a	Overlapped CNVs	n/a
34	rs577988098	chr17:18284296-18284297	Weak transcription Enhancers Bivalent Enhancer Strong transcription	n/a	n/a	Overlapped CNVs	n/a
35	rs189648449	chr17:18284317-18284318	Weak transcription Enhancers Bivalent Enhancer Strong transcription	n/a	n/a	Overlapped CNVs	n/a
36	rs144581987	chr17:18284326-18284327	Weak transcription Enhancers Bivalent Enhancer Strong transcription	n/a	n/a	Overlapped CNVs	n/a
37	rs574213593	chr17:18284351-18284352	Weak transcription Enhancers Bivalent Enhancer Strong transcription	n/a	n/a	Overlapped CNVs	n/a
38	rs542841181	chr17:18284411-18284412	Weak transcription Enhancers Bivalent Enhancer Strong transcription	n/a	n/a	Overlapped CNVs	n/a
39	rs562712110	chr17:18284412-18284413	Weak transcription Enhancers Bivalent Enhancer Strong transcription	n/a	n/a	Overlapped CNVs	n/a
40	rs576363119	chr17:18284453-18284454	Weak transcription Enhancers Bivalent Enhancer Strong transcription	n/a	n/a	Overlapped CNVs	n/a
41	rs148487221	chr17:18284476-18284477	Weak transcription Enhancers Bivalent Enhancer Strong transcription	n/a	n/a	Overlapped CNVs	n/a
42	rs180829251	chr17:18284506-18284507	Weak transcription Enhancers Bivalent Enhancer Strong transcription	n/a	n/a	Overlapped CNVs	n/a
43	rs7501705	chr17:18284511-18284512	Weak transcription Enhancers Bivalent Enhancer Strong transcription	n/a	n/a	Overlapped CNVs	n/a
44	rs530622383	chr17:18284537-18284538	Weak transcription Enhancers Bivalent Enhancer Strong transcription	n/a	n/a	Overlapped CNVs	n/a
45	rs527294156	chr17:18284539-18284540	Weak transcription Enhancers Bivalent Enhancer Strong transcription	n/a	n/a	Overlapped CNVs	n/a
46	rs547108851	chr17:18284556-18284557	Weak transcription Enhancers Bivalent Enhancer Strong transcription	n/a	n/a	Overlapped CNVs	n/a
47	rs187614461	chr17:18284631-18284632	Weak transcription Enhancers Bivalent/Poised TSS Strong transcription	n/a	n/a	Overlapped CNVs	n/a
48	rs375878972	chr17:18284649-18284650	Weak transcription Enhancers Bivalent/Poised TSS Strong transcription	n/a	n/a	Overlapped CNVs	n/a
49	rs529782002	chr17:18284683-18284684	Weak transcription Enhancers Bivalent/Poised TSS Strong transcription	n/a	n/a	Overlapped CNVs	n/a
50	rs549126432	chr17:18284745-18284746	Weak transcription Enhancers Bivalent/Poised TSS Strong transcription	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:169)

Disease	PMID	Source
Chronic lymphocytic leukemia	21546498	CNVD
Burkitt''s lymphoma	19759907	CNVD
Wilms tumour	21544195	CNVD
Esophageal adenocarcinoma	18519675	CNVD
lymphocytic leukemia	21291569	CNVD
Acute lymphoblastic leukemia	21390130	CNVD
Melanoma	18172304	CNVD
Medulloblastoma	21979893	CNVD
Breast cancer	16608533	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Chordoma	21602918	CNVD
Miller-Dieker syndrome	22283845	CNVD
Non-syndromic sensorineural hearing loss	17457615	CNVD
Cancer	22429812	CNVD
Chronic lymphocytic leukemia	21795749	CNVD
Ewing''s sarcoma	21437220	CNVD
Follicular lymphoma	19010834	CNVD
Colorectal cancer	20709793	CNVD
Acute myeloid leukemia	16864856	CNVD
Endometrial cancer	22040021	CNVD
Paraganglioma	21461997	CNVD
Pheochromocytoma	21461997	CNVD
Breast cancer	22028636	CNVD
Breast cancer	20837533	CNVD
Astrocytoma	17387387	CNVD
Breast cancer	21264507	CNVD
Hepatocellular carcinoma	22174799	CNVD
Medulloblastoma	21292688	CNVD
colon cancer	17210682	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Basal cell lymphoma	17053054	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Cancer	16751803	CNVD
Endometrioid adenocarcinoma	16974079	CNVD
Colorectal cancer	19359472	CNVD
Embryonal rhabdomyosarcoma	16790082	CNVD
Chronic lymphocytic leukemia	17971485	CNVD
Basal cell lymphoma	17170743	CNVD
Breast cancer	16461572	CNVD
Colorectal cancer	16272173	CNVD
Follicular lymphoma	17170743	CNVD
Human rectal carcinomas	16397240	CNVD
Oral squamous cell carcinoma	17134496	CNVD
Breast cancer	17133270	CNVD
Chronic lymphocytic leukemia	18922857	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Glioblastoma multiforme	21080181	CNVD
Ovarian cancer	22174824	CNVD
Moyamoya disease	22323933	CNVD
small cell lung cancer	20016488	CNVD
Acute myeloid leukemia	20729466	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Acute promyelocytic leukemia	19109227	CNVD
Urothelial carcinoma	21177765	CNVD
Acute myeloid leukemia	21251322	CNVD
Myelodysplastic syndrome	21251322	CNVD
Cancer	20164919	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Thoracic aortic aneurysm	21092924	CNVD
Acute myeloid leukemia	20724749	CNVD
Non-syndromic sensorineural hearing loss	21030649	CNVD
Acute myeloid leukemia	17237825	CNVD
Colorectal cancer	21645411	CNVD
HIV/AIDS	22844521	CNVD
Psoriasis	22844521	CNVD
Rheumatoid arthritis	22844521	CNVD
Sclerosis systemic	22844521	CNVD
Systemic lupus erythematosus	22844521	CNVD
HIV/AIDS	17953491	CNVD
HIV/AIDS	20877625	CNVD
Immune disease	21076436	CNVD
Rheumatoid arthritis	17953491	CNVD
Type 1 diabetes	17953491	CNVD
HIV/AIDS	15637236	CNVD
Prostate cancer	18632612	CNVD
Lung cancer	18438408	CNVD
Ovarian cancer	21781307	CNVD
Autism	22495311	CNVD
Breast cancer	20668451	CNVD
Cancer	20668451	CNVD
Lung cancer	20668451	CNVD
Ovarian cancer	20668451	CNVD
Pancreas cancer	20668451	CNVD
Prostate cancer	20668451	CNVD
Neurofibromatosis	18196300	CNVD
Adenoid cystic carcinoma	18332873	CNVD
Colorectal cancer	16774939	CNVD
Breast cancer	17001317	CNVD
Rhabdomyosarcoma	16790082	CNVD
Charcot-marie-tooth disease	16463004	CNVD
Osteosarcoma	22292074	CNVD
Breast cancer	17603634	CNVD
Charcot	16760730	CNVD
Mental retardation	17901693	CNVD
Malignant fibrous histiocytomas	21085701	CNVD
ovarian endometriomas	16273235	CNVD
Ovarian cancer	21720365	CNVD
Acute lymphoblastic leukemia	21339820	CNVD
Smith-Magenis syndrome	18923513	CNVD
Invasive pancreatic ductal carcinoma	16982739	CNVD
Myelofibrosis	22110671	CNVD
Breast cancer	16272173	CNVD
Austim spectrum disorder	21302340	CNVD
Autism	22492990	CNVD
Congenital abnormalities	21549014	CNVD
Developmental delay	18414209	CNVD
Developmental delay	21549014	CNVD
Epilepsy	20970697	CNVD
Mental retardation	18414209	CNVD
Mental retardation	21549014	CNVD
Smith-Magenis syndrome	21981782	CNVD
Smith-Magenis syndrome	20188345	CNVD
Smith-Magenis syndrome	16775514	CNVD
Smith-Magenis syndrome	22585170	CNVD
Smith-Magenis syndrome	22241247	CNVD
Autism	20970697	CNVD
Mental retardation	19951919	CNVD
Potocki-Lupski syndrome	21271655	CNVD
Potocki-lupski syndrome	17357070	CNVD
Potocki-lupski syndrome	20110824	CNVD
Potocki-lupski syndrome	18923514	CNVD
Potocki-lupski syndrome	22241247	CNVD
Potocki-lupski syndrome	20188345	CNVD
Schizophrenia	21399695	CNVD
Mental retardation	16773131	CNVD
Adenocarcinoma	19607727	CNVD
Squamous cell cancer	19607727	CNVD
Non-small cell lung cancer	21829676	CNVD
Glioblastoma multiforme	17002787	CNVD
Charcot-marie-tooth disease	22470819	CNVD
Neurofibromatosis	22470819	CNVD
Neuropathy	22470819	CNVD
Smith-Magenis syndrome	18301319	CNVD
Smith-Magenis syndrome	17357070	CNVD
Smith-Magenis syndrome	18469339	CNVD
Smith-Magenis syndrome	22241097	CNVD
Smith-Magenis syndrome	22470819	CNVD
Tourette syndrome	18923514	CNVD
Type 1 diabetes	22470819	CNVD
Potocki-lupski syndrome	18469339	CNVD
Follicular lymphoma	20505157	CNVD
T-cell lymphomas	19863542	CNVD
Neuropathy	17597781	CNVD
Hepatocellular carcinoma	16750200	CNVD
Neurodevelopmental disorder	17015230	CNVD
Smith-Magenis syndrome	17597781	CNVD
Potocki-lupski syndrome	18059269	CNVD
Potocki-lupski syndrome	17597781	CNVD
Mental retardation	17847001	CNVD
Multiple myeloma	16616336	CNVD
Breast cancer	20409316	CNVD
Non-syndromic sensorineural hearing loss	18496225	CNVD
Autism	22543975	CNVD
Ovarian cancer	22355333	CNVD
Pancreatic ductal adenocarcinoma	19077451	CNVD
Sezary syndrome	18413736	CNVD
Medulloblastoma	16783165	CNVD
Recurrent pregnancy loss	19789632	CNVD
Non-syndromic sensorineural hearing loss	17122850	CNVD
early-passage human iPS cells	21368824	CNVD
Breast cancer	21509527	CNVD
Breast cancer	22522925	CNVD
Non-syndromic sensorineural hearing loss	21293372	CNVD
Tetralogy of Fallot	22912587	CNVD
Ovarian clear cell carcinoma	21343371	CNVD
Autism	21865298	CNVD
Pancreatic cancer	17952125	CNVD
Non-syndromic sensorineural hearing loss	19212409	CNVD

Chromatin state (count:977 , 50 per page) page: 1 2 3 4 5 6 7 ... 20

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr17:18267200-18288200	Weak transcription	Right Atrium	heart
2	chr17:18280400-18284200	Enhancers	Stomach Mucosa	stomach
3	chr17:18280600-18283800	Enhancers	Placenta	Placenta
4	chr17:18281400-18286400	Weak transcription	Gastric	stomach
5	chr17:18281600-18283800	Weak transcription	Primary hematopoietic stem cells G-CSF-mobilized Male	--
6	chr17:18282600-18283800	Enhancers	Esophagus	oesophagus
7	chr17:18283000-18283800	Enhancers	Rectal Mucosa Donor 29	rectum
8	chr17:18283000-18283800	Bivalent Enhancer	NHEK	skin
9	chr17:18283000-18288200	Enhancers	Fetal Thymus	thymus
10	chr17:18283200-18283800	Enhancers	Foreskin Keratinocyte Primary Cells skin03	Skin
11	chr17:18283400-18283800	Enhancers	HUES6 Cell Line	embryonic stem cell
12	chr17:18283400-18287000	Enhancers	iPS DF 19.11 Cell Line	embryonic stem cell
13	chr17:18283600-18283800	Bivalent Enhancer	Primary Natural Killer cells fromperipheralblood	blood
14	chr17:18283600-18284000	Enhancers	ES-WA7 Cell Line	embryonic stem cell
15	chr17:18283600-18284000	Enhancers	ES-UCSF4 Cell Line	embryonic stem cell
16	chr17:18283600-18284000	Bivalent Enhancer	Primary monocytes fromperipheralblood	blood
17	chr17:18283600-18284000	Bivalent Enhancer	Monocytes-CD14+_RO01746	blood
18	chr17:18283800-18284000	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Female	--
19	chr17:18283800-18284000	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Male	--
20	chr17:18283800-18284000	Bivalent Enhancer	Placenta	Placenta
21	chr17:18283800-18284200	Weak transcription	Esophagus	oesophagus
22	chr17:18283800-18284800	Weak transcription	Rectal Mucosa Donor 29	rectum
23	chr17:18283800-18286200	Weak transcription	HUES6 Cell Line	embryonic stem cell
24	chr17:18283800-18289400	Weak transcription	Foreskin Keratinocyte Primary Cells skin03	Skin
25	chr17:18284000-18284200	Bivalent Enhancer	Primary hematopoietic stem cells G-CSF-mobilized Male	--
26	chr17:18284000-18284200	Bivalent Enhancer	Foreskin Melanocyte Primary Cells skin01	Skin
27	chr17:18284000-18284600	Bivalent Enhancer	Foreskin Fibroblast Primary Cells skin02	Skin
28	chr17:18284000-18286200	Weak transcription	ES-UCSF4 Cell Line	embryonic stem cell
29	chr17:18284200-18286000	Strong transcription	Esophagus	oesophagus
30	chr17:18284600-18285200	Bivalent/Poised TSS	Foreskin Fibroblast Primary Cells skin02	Skin
31	chr17:18285000-18285200	Bivalent Enhancer	H1 Derived Mesenchymal Stem Cells	ES cell derived
32	chr17:18285000-18285200	Bivalent Enhancer	Duodenum Mucosa	Duodenum
33	chr17:18285400-18286400	Bivalent Enhancer	Foreskin Melanocyte Primary Cells skin01	Skin
34	chr17:18285800-18286000	Bivalent/Poised TSS	Foreskin Fibroblast Primary Cells skin02	Skin
35	chr17:18285800-18287000	Bivalent Enhancer	Primary T cells fromperipheralblood	blood
36	chr17:18286000-18286200	Enhancers	Thymus	Thymus
37	chr17:18286000-18286400	Bivalent Enhancer	Foreskin Fibroblast Primary Cells skin02	Skin
38	chr17:18286000-18286600	Enhancers	iPS DF 6.9 Cell Line	embryonic stem cell
39	chr17:18286000-18286600	Enhancers	Primary T regulatory cells fromperipheralblood	blood
40	chr17:18286200-18286400	Bivalent Enhancer	Breast Myoepithelial Primary Cells	Breast
41	chr17:18286200-18286400	Bivalent Enhancer	Primary hematopoietic stem cells G-CSF-mobilized Male	--
42	chr17:18286200-18286400	Bivalent Enhancer	Foreskin Melanocyte Primary Cells skin03	Skin
43	chr17:18286200-18286400	Enhancers	Rectal Mucosa Donor 29	rectum
44	chr17:18286200-18286400	Bivalent Enhancer	Right Ventricle	heart
45	chr17:18286200-18286400	Bivalent Enhancer	Skeletal Muscle Male	skeletal muscle
46	chr17:18286200-18286400	Bivalent Enhancer	Spleen	Spleen
47	chr17:18286200-18286600	Enhancers	HUES6 Cell Line	embryonic stem cell
48	chr17:18286200-18286600	Enhancers	ES-UCSF4 Cell Line	embryonic stem cell
49	chr17:18286200-18286600	Bivalent Enhancer	Primary B cells from peripheral blood	blood
50	chr17:18286200-18286600	Active TSS	Primary T helper naive cells fromperipheralblood	blood

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links